Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
about
Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARgamma activation in human gingival fibroblasts.Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancerCellular and molecular consequences of peroxisome proliferator-activated receptor-gamma activation in ovarian cancer cells.Effect of polyunsaturated fatty acids and their metabolites on bleomycin-induced cytotoxic action on human neuroblastoma cells in vitro.Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer managementFunction of PPARgamma and its ligands in lung cancer.Peroxisome proliferator-activated receptors in lung cancer.Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancerPPARgamma in Neuroblastoma.PPARgamma and Apoptosis in Cancer.Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells.PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive AgentsThiazolidinediones as anti-cancer agents.Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention.Phosphorylation of Human Retinoid X Receptor α at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1α,25-Dihydroxyvitamin D3-dependent DNA Binding in Ras-transformed Keratinocytes.DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention.LOX/COX inhibitors enhance the antineoplastic effects of all-trans retinoic acid in osteosarcoma cell lines.Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.Inhibitory effect of celecoxib in lung carcinoma by regulation of cyclooxygenase-2/cytosolic phospholipase A₂ and peroxisome proliferator-activated receptor gamma.Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.The ATRA-induced differentiation of medulloblastoma cells is enhanced with LOX/COX inhibitors: an analysis of gene expression.Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.Protein profiling of plasma membranes defines aberrant signaling pathways in mantle cell lymphoma.Combination Therapy of PPARgamma Ligands and Inhibitors of Arachidonic Acid in Lung CancerAS601245, an Anti-Inflammatory JNK Inhibitor, and Clofibrate Have a Synergistic Effect in Inducing Cell Responses and in Affecting the Gene Expression Profile in CaCo-2 Colon Cancer Cells.Simultaneous inhibition of COX-2 and activation of PPAR-γ resulted in the same level and pattern of neuroprotection as they were targeted separately.Metal free sulfenylation and bis-sulfenylation of indoles: persulfate mediated synthesis.Fixed-Dose Combinations of Pioglitazone and Metformin for Lung Cancer Prevention.Differential action of polyunsaturated fatty acids and eicosanoids on bleomycin-induced cytotoxicity to neuroblastoma cells and lymphocytes.Constraint based modeling of metabolism allows finding metabolic cancer hallmarks and identifying personalized therapeutic windows.miR-146a suppresses 5-lipoxygenase activating protein (FLAP) expression and Leukotriene B4 production in lung cancer cells.
P2860
Q30830094-3C9391ED-8184-48FB-A265-EEE6CF86C27FQ34878637-FF05EE15-CF52-4EE9-8FF9-45CCB2780300Q35249254-A5AEFE2A-5386-4D99-AE71-9FB3B1A5A807Q35533273-DF9A9A94-C188-4A51-93B2-A99586598536Q36172739-73398A98-7DA9-43B4-B7B1-249C31A4E389Q36414175-0B191686-6480-4A73-9F0E-B62358DF1190Q36417658-E5422EA0-7DFC-43CD-8663-8E15922BAD22Q36661722-35463BDF-35E0-4CD9-84D8-41B92D7F4A67Q36678476-B1A8F65E-016F-44D8-8F9D-30A5981875F3Q36742811-202C4278-36D1-492F-805C-2C9F9BD32D6DQ36836697-C1138D74-053E-40E8-8804-F48E2DAC41F1Q36859555-9BA02268-209D-41F0-9B9C-6131C5E327B1Q37010188-8E2C75B1-E8FE-4FAF-8DEF-D4D15EFE7522Q37963769-B025D5A0-9825-4A49-80CC-341BA8B1C1CAQ38730810-D07106B9-AA11-441D-8402-F604ABECEF28Q38936688-792E3E39-6A35-4949-A5FB-3C612EE1B9FFQ38998207-D45DED8F-0C63-466A-8A66-7125CCB4B8BEQ39522931-60FE7B12-E7C3-4E21-81E3-2BBB1DE3F9E8Q39544858-F08698E6-36ED-4AC8-AF4D-0168DDB04F17Q39650265-ADE5C0ED-3405-4199-B696-E0F84C7112E3Q40999604-297C782A-EA42-4276-BEA9-AE40FBBF2B77Q41587393-524DAC76-13FC-41C7-B1DE-871C48BFF833Q41971312-FCC89891-B5BC-4622-AA39-DC56902FDAACQ42126506-117DBA3B-AEA3-49BB-8466-67A7E994155FQ42155839-BB1EA529-611F-4DE1-A762-07A0F63D9F08Q45041925-A095DF77-3956-4E55-94A7-5EB514D89339Q46072651-A632CD82-177C-4755-8F51-0CBB59ADCE8FQ47133208-E390A5FD-FE84-43AB-B740-5D41089EB982Q49379499-55730CBC-2243-4725-9A03-563DB49FF0A5Q55246059-53DFE2F5-2452-43A1-BE89-958C62CFB3ADQ55382726-C7CF85B1-48FD-4155-8775-0340608AE557
P2860
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Inhibitors of the arachidonic ...... lung cancer growth inhibition.
@en
type
label
Inhibitors of the arachidonic ...... lung cancer growth inhibition.
@en
prefLabel
Inhibitors of the arachidonic ...... lung cancer growth inhibition.
@en
P2093
P1433
P1476
Inhibitors of the arachidonic ...... lung cancer growth inhibition.
@en
P2093
Anatoly Mayburd
Enrique Zudaire
Frank Ondrey
Ingalill Avis
James L Mulshine
Jordi Tauler
Raed Abu-Ghazaleh
P304
P356
10.1158/0008-5472.CAN-04-3441
P407
P50
P577
2005-05-01T00:00:00Z